# The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998, Schedule THE: ENTRIES INSERTED IN SCHEDULE 1 TO THE PRINCIPAL ORDER


Column 1
Column 2
Column 3
Column 4
Column 5
Substance
Maximum strength
Route of administration, use or pharmaceutical form
Treatment limitations
Maximum quantity
Aloxiprin
(1) 620 mg
(1) Non-effervescent tablets and capsules
(1) The quantity sold or supplied in one container or package shall not exceed 32
The quantity of non-effervescent tablets, capsules or a combination of both sold or supplied to a person at any one time shall not exceed 100
(2) All preparations other than non-effervescent tablets or capsules
Diphenhydramine Hydrochloride
All preparations except liquid-filled capsules
Hydrocyanic Acid
Ibuprofen Lysine
Rheumatic and muscular pain, pain of non-serious arthritic conditions, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of colds and influenza
Internal
(a) In the case of a prolonged release preparation 600 mg (MD) 1,200 mg (MDD)
(b) in any other case 400 mg (MD) 1,200 mg (MDD)
Levocabastine Hydrochloride
Equivalent of 0.05 per cent Levocabastine
(1) Nasal sprays
For the symptomatic treatment of seasonal allergic rhinitis
(1) Container or package containing not more than 10 ml of medicinal product
(2) Aqueous eye drops
For the symptomatic treatment of seasonal allergic conjunctivitis
(2) Container or package containing not more than 4 ml of medicinal product
Nilutamide
Phytomenadione
Any use except the prevention or treatment of haemorrhagic disorders
Strychnine Nitrate
Sulfabenzamide

---
Source: https://www.legislation.gov.uk/uksi/1998/2081/schedule (the official version)
Page: https://openlegislation.uk/prescription-only-medicines-human-use-amendment-no-3-order-1998/schedule
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.